Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Systematic Review of Human Challenge Trials, Designs, and Safety

Jupiter Adams-Phipps, View ORCID ProfileDanny Toomey, View ORCID ProfileWitold Więcek, View ORCID ProfileVirginia Schmit, James Wilkinson, View ORCID ProfileKeller Scholl, View ORCID ProfileEuzebiusz Jamrozik, View ORCID ProfileJoshua Osowicki, View ORCID ProfileMeta Roestenberg, View ORCID ProfileDavid Manheim
doi: https://doi.org/10.1101/2022.03.20.22272658
Jupiter Adams-Phipps
11Day Sooner Research Team, Delaware, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danny Toomey
11Day Sooner Research Team, Delaware, USA
2Department of Medical Science, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Danny Toomey
Witold Więcek
11Day Sooner Research Team, Delaware, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Witold Więcek
Virginia Schmit
11Day Sooner Research Team, Delaware, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Virginia Schmit
James Wilkinson
11Day Sooner Research Team, Delaware, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keller Scholl
3RAND Corporation, Pardee RAND Graduate School, Santa Monica, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Keller Scholl
Euzebiusz Jamrozik
4The Ethox Centre & Wellcome Centre for Ethics and the Humanities, Nuffield Department of Population Health, University of Oxford, Oxford, UK
5Monash Bioethics Centre, Monash University, Clayton, VIC, Australia
6Royal Melbourne Hospital Department of Medicine, University of Melbourne, Parkville, VIC, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Euzebiusz Jamrozik
Joshua Osowicki
7Infectious Diseases Unit, Department of General Medicine, Royal Children’s Hospital Melbourne, Parkville, VIC, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua Osowicki
Meta Roestenberg
9Department of Parasitology, Leiden University Medical Centre, Leiden, The Netherlands
10Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Meta Roestenberg
David Manheim
11Day Sooner Research Team, Delaware, USA
11Technion, Israel Institute of Technology, Haifa, Israel
12ALTER, Association for Long Term Existence and Resilience, Rehovot, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Manheim
  • For correspondence: david@1daysooner.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background There exists no prior systematic review of human challenge trials (HCTs) that focuses on participant safety. Key questions regarding HCTs include how risky such trials have been, how often adverse events (AEs) and serious adverse events (SAEs) occur, and whether risk mitigation measures have been effective.

Methods A systematic search of PubMed and PubMed Central for articles reporting on results of HCTs published between 1980 and 2021 was performed and completed by 10/7/2021.

Results Of 2,838 articles screened, 276 were reviewed in full. 15,046 challenged participants were described in 308 studies that met inclusion criteria. 286 (92.9%) of these studies reported mitigation measures used to minimize risk to the challenge population. Among 187 studies which reported on SAEs, 0.2% of participants experienced at least one challenge-related SAE. Among 94 studies that graded AEs by severity, challenge-related AEs graded “severe” were reported by between 5.6% and 15.8% of participants. AE data were provided as a range to account for unclear reporting. 80% of studies published after 2010 were registered in a trials database.

Conclusions HCTs are increasingly common and used for an expanding list of diseases. Although AEs occur, severe AEs and SAEs are rare. Reporting has improved over time, though not all papers provide a comprehensive report of relevant health impacts. From the available data, most HCTs do not lead to a high number of severe symptoms or SAEs. This study was preregistered on PROSPERO as CRD42021247218.

Competing Interest Statement

1DaySooner advocates for volunteers in HCTs and supports their broader usage. Several authors of the paper have volunteered for HCTs, though none have participated in a trial. Several authors of the paper were employed by 1DaySooner's research team for this work, which is intended to be independent of the advocacy group. For this reason, there was no review of the manuscript nor input about the results from the management nor from the advocacy team. DM has been paid externally for work with both the advocacy and research teams at 1DaySooner, as well as other related advocacy and policy research. WW provides scientific consulting for pharmaceutical companies and other organizations which conduct clinical trials, but not for HCTs. MR is a professor and the clinical head of the Controlled Human Infection Center at Leiden University, which conducts challenge trials. JO has worked on challenge trials, and is working with an international collaborative group to drive development of a GAS pharyngitis CHIM. EJ has contributed to WHO Ethics Guidance documents on Human Challenge Trials and has received funding from the Wellcome Trust, including current grants 221719 and 216355, which supported work for this paper.

Funding Statement

This work was supported by 1Day Sooner. David Manheim was supported by grants from the Center for Effective Altruism's Long Term Future Fund. Euzebius Jamrozik's work was supported by the Wellcome Trust, including current grants 221719 and 216355.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data is publicly available online at https://github.com/1DaySooner/HCTSystematicReview

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 21, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Systematic Review of Human Challenge Trials, Designs, and Safety
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Systematic Review of Human Challenge Trials, Designs, and Safety
Jupiter Adams-Phipps, Danny Toomey, Witold Więcek, Virginia Schmit, James Wilkinson, Keller Scholl, Euzebiusz Jamrozik, Joshua Osowicki, Meta Roestenberg, David Manheim
medRxiv 2022.03.20.22272658; doi: https://doi.org/10.1101/2022.03.20.22272658
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A Systematic Review of Human Challenge Trials, Designs, and Safety
Jupiter Adams-Phipps, Danny Toomey, Witold Więcek, Virginia Schmit, James Wilkinson, Keller Scholl, Euzebiusz Jamrozik, Joshua Osowicki, Meta Roestenberg, David Manheim
medRxiv 2022.03.20.22272658; doi: https://doi.org/10.1101/2022.03.20.22272658

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (528)
  • Anesthesia (126)
  • Cardiovascular Medicine (1450)
  • Dentistry and Oral Medicine (221)
  • Dermatology (161)
  • Emergency Medicine (293)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (591)
  • Epidemiology (10353)
  • Forensic Medicine (6)
  • Gastroenterology (536)
  • Genetic and Genomic Medicine (2668)
  • Geriatric Medicine (258)
  • Health Economics (501)
  • Health Informatics (1758)
  • Health Policy (794)
  • Health Systems and Quality Improvement (685)
  • Hematology (270)
  • HIV/AIDS (573)
  • Infectious Diseases (except HIV/AIDS) (12145)
  • Intensive Care and Critical Care Medicine (651)
  • Medical Education (276)
  • Medical Ethics (84)
  • Nephrology (293)
  • Neurology (2502)
  • Nursing (145)
  • Nutrition (384)
  • Obstetrics and Gynecology (503)
  • Occupational and Environmental Health (571)
  • Oncology (1344)
  • Ophthalmology (408)
  • Orthopedics (153)
  • Otolaryngology (241)
  • Pain Medicine (174)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (791)
  • Pharmacology and Therapeutics (337)
  • Primary Care Research (300)
  • Psychiatry and Clinical Psychology (2434)
  • Public and Global Health (5051)
  • Radiology and Imaging (904)
  • Rehabilitation Medicine and Physical Therapy (537)
  • Respiratory Medicine (690)
  • Rheumatology (309)
  • Sexual and Reproductive Health (258)
  • Sports Medicine (246)
  • Surgery (301)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (109)